Xenetic Biosciences (XBIO) Revenue & Revenue Breakdown
Xenetic Biosciences Revenue Highlights
Latest Revenue (Y)
$2.54M
Latest Revenue (Q)
$510.82K
Main Segment (Y)
Royalty Revenue
Main Geography (Y)
Royalty Revenue
Xenetic Biosciences Revenue by Period
Xenetic Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.54M | 48.80% |
| 2022-12-31 | $1.71M | 47.06% |
| 2021-12-31 | $1.16M | 165.64% |
| 2020-12-31 | $436.94K | 2460.31% |
| 2019-12-31 | $17.07K | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2017-12-31 | $7.58M | 152.83% |
| 2016-12-31 | $3.00M | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $1.00M | 240.60% |
| 2012-12-31 | $293.60K | - |
Xenetic Biosciences generated $2.54M in revenue during NA 2023, up 48.80% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Xenetic Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $510.82K | -23.98% |
| 2023-12-31 | $671.96K | 9.95% |
| 2023-09-30 | $611.17K | -6.12% |
| 2023-06-30 | $651.00K | 7.45% |
| 2023-03-31 | $605.84K | 24.41% |
| 2022-12-31 | $486.97K | 17.56% |
| 2022-09-30 | $414.25K | -0.59% |
| 2022-06-30 | $416.71K | 7.13% |
| 2022-03-31 | $388.99K | 16.95% |
| 2021-12-31 | $332.60K | -4.77% |
| 2021-09-30 | $349.27K | 21.44% |
| 2021-06-30 | $287.60K | 50.41% |
| 2021-03-31 | $191.22K | 26.36% |
| 2020-12-31 | $151.33K | 30.53% |
| 2020-09-30 | $115.93K | 2.66% |
| 2020-06-30 | $112.93K | 98.99% |
| 2020-03-31 | $56.75K | 232.53% |
| 2019-12-31 | $17.07K | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $7.50M | 8723.53% |
| 2017-09-30 | $85.00K | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $3.00M | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | -100.00% |
| 2013-11-30 | $2.17K | -126.98% |
| 2013-08-31 | $-8.04K | -120.40% |
| 2013-05-31 | $39.41K | 21.05% |
| 2013-02-28 | $32.56K | -1.23% |
| 2012-11-30 | $32.96K | 23.74% |
| 2012-08-31 | $26.64K | -26.87% |
| 2012-05-31 | $36.43K | 1.29% |
| 2012-02-29 | $35.97K | 161.60% |
| 2011-11-30 | $13.75K | - |
Xenetic Biosciences generated $510.82K in revenue during Q1 2024, up -23.98% compared to the previous quarter, and up 104.90% compared to the same period a year ago.
Xenetic Biosciences Revenue Breakdown
Xenetic Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 |
|---|---|
| Royalty Revenue | $437.00K |
Xenetic Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 20: Royalty Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|
| Royalty Revenue | $300.00K | $300.00K | $151.00K | $17.00K | - | - | - | - |
| RoyaltyRevenueMember | - | - | $200.00K | $116.00K | $113.00K | $57.00K | - | - |
Xenetic Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Royalty Revenue (100.00%).
Xenetic Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| Royalty Revenue | $437.00K |
Xenetic Biosciences's latest annual revenue breakdown by geography, as of Dec 20: Royalty Revenue (100.00%).
Quarterly Revenue by Country
| Country | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|
| Royalty Revenue | $300.00K | $300.00K | $151.00K | $17.00K | - | - | - | - |
| RoyaltyRevenueMember | - | - | $200.00K | $116.00K | $113.00K | $57.00K | - | - |
Xenetic Biosciences's latest quarterly revenue breakdown by geography, as of Sep 21: Royalty Revenue (100.00%).
Xenetic Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| YS | LakeShore Biopharma | $687.20M | $164.98M |
| TNXP | Tonix Pharmaceuticals | $7.77M | $2.21M |
| XBIO | Xenetic Biosciences | $2.54M | $510.82K |
| PALI | Palisade Bio | $250.00K | - |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| CYTO | Altamira Therapeutics | - | $52.73K |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| ATNF | 180 Life Sciences | - | - |
| DRUG | Bright Minds Biosciences | - | - |
| GOVX | GeoVax Labs | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| IMMX | Immix Biopharma | - | - |
| ONCR | Oncorus | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| LABP | Landos Biopharma | - | - |
| ENVB | Enveric Biosciences | - | - |
| NEXI | NexImmune | - | - |
XBIO Revenue FAQ
What is Xenetic Biosciences’s yearly revenue?
Xenetic Biosciences's yearly revenue for 2023 was $2.54M, representing an increase of 48.80% compared to 2022. The company's yearly revenue for 2022 was $1.71M, representing an increase of 47.06% compared to 2021. XBIO's yearly revenue for 2021 was $1.16M, representing an increase of 165.64% compared to 2020.
What is Xenetic Biosciences’s quarterly revenue?
Xenetic Biosciences's quarterly revenue for Q1 2024 was $510.82K, a -23.98% decrease from the previous quarter (Q4 2023), and a -15.69% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $671.96K, a 9.95% increase from the previous quarter (Q3 2023), and a 37.99% increase year-over-year (Q4 2022). XBIO's quarterly revenue for Q3 2023 was $611.17K, a -6.12% decrease from the previous quarter (Q2 2023), and a 47.54% increase year-over-year (Q3 2022).
What is Xenetic Biosciences’s revenue growth rate?
Xenetic Biosciences's revenue growth rate for the last 3 years (2021-2023) was 118.83%, and for the last 5 years (2019-2023) was 14783.31%.
What are Xenetic Biosciences’s revenue streams?
Xenetic Biosciences's revenue streams in c 20 are Royalty Revenue
What is Xenetic Biosciences’s main source of revenue?
For the fiscal year ending Dec 20, the largest source of revenue of Xenetic Biosciences was Royalty Revenue. This segment made a revenue of $437K, representing 100.00% of the company's total revenue.